Sequenom Shares Rise Sharply on Licensing Deal | GenomeWeb
Shares of Sequenom rose 23 percent for the five-day trading period ended Tuesday to lead all gainers in the BCW Index. The firm’s shares jumped 16 percent on Tuesday alone after the firm announced that it had licensed a next-generation sequencing technology from Harvard University (see Briefs).
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.